90 Recruiting Studies Using Tacrolimus
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Tacrolimus
Itacitinib for the Prevention of Graft Versus Host Disease
📍 M D Anderson Cancer Center — Houston, Texas
Hematologic and Lymphocytic Disorder
View Study & Checklist ➔Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita
📍 University of Chicago — Chicago, Illinois
Dyskeratosis Congenita
View Study & Checklist ➔Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
📍 City of Hope Medical Center — Duarte, California
Allogeneic Hematopoietic Stem Cell Transplant Recipient
View Study & Checklist ➔Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia
📍 City of Hope Medical Center — Duarte, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
📍 University of Colorado — Aurora, Colorado
Hematologic Diseases
View Study & Checklist ➔Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia
📍 City of Hope Medical Center — Duarte, California
Adult Acute Lymphoblastic Leukemia in Remission
View Study & Checklist ➔Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Primary Myelofibrosis
View Study & Checklist ➔Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
📍 M D Anderson Cancer Center — Houston, Texas
Hematopoietic and Lymphoid Cell Neoplasm
View Study & Checklist ➔A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy
📍 Amicis Research Center — Granada Hills, California
Primary Membranous Nephropathy
View Study & Checklist ➔Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Lymphoproliferative Disorders
View Study & Checklist ➔Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
📍 NYU Langone Health — New York, New York
Graft Vs Host Disease
View Study & Checklist ➔HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
📍 City of Hope National Medical Center — Duarte, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Blood Stem Cell Transplant for Sickle Cell Disease
📍 City of Hope Medical Center — Duarte, California
Sickle Cell Disease
View Study & Checklist ➔Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
📍 Masonic Cancer Center at University of Minnesota — Minneapolis, Minnesota
Acute Myeloid Leukemia
View Study & Checklist ➔Envarsus XR® in Adolescent Renal Transplant Recipients
📍 UCLA Transplantation Services — Los Angeles, California
Kidney Transplantation
View Study & Checklist ➔BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)
📍 Cedars-Sinai Medical Center- Site Number : 8400100 — Los Angeles, California
Transplant Rejection
View Study & Checklist ➔Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
📍 Washington University — St Louis, Missouri
Lymphoma, Non-Hodgkin
View Study & Checklist ➔Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis
📍 City of Hope Medical Center — Duarte, California
Secondary Myelofibrosis
View Study & Checklist ➔Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes
📍 University of Illinois at Chicago — Chicago, Illinois
Acute Myeloid Leukemia
View Study & Checklist ➔Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
Acute Lymphoblastic Leukemia (ALL)
View Study & Checklist ➔HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
📍 Mayo Clinic Arizona — Phoenix, Arizona
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
📍 Ironwood Cancer and Research Center — Chandler, Arizona
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation
📍 Washington University School of Medicine — St Louis, Missouri
Acute Myeloid Leukemia
View Study & Checklist ➔Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
📍 M D Anderson Cancer Center — Houston, Texas
Recurrent Acute Myeloid Leukemia
View Study & Checklist ➔Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants
📍 City of Hope Medical Center — Duarte, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
GATA2
View Study & Checklist ➔Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)
📍 Vancouver General Hospital — Vancouver, British Columbia
Organ Transplant Failure or Rejection
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
📍 Kaiser Permanente - San Francisco Medical Center — San Francisco, California
Primary Membranous Nephropathy
View Study & Checklist ➔Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
📍 Banner University Medical Center - Tucson — Tucson, Arizona
Acute Lymphoblastic Leukemia
View Study & Checklist ➔De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis
📍 Froedtert Hospital & the Medical College of Wisconsin — Milwaukee, Wisconsin
Graft-versus-host Disease
View Study & Checklist ➔Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
📍 Stanford University — Stanford, California
Allogeneic Hematopoietic Cell Transplantation (HCT)
View Study & Checklist ➔Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
📍 Moffitt Cancer Center - McKinley Campus — Tampa, Florida
Clinical Stage III Cutaneous Melanoma AJCC v8
View Study & Checklist ➔Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant
📍 Einstein Medical Center — Philadelphia, Pennsylvania
Post Liver Transplant
View Study & Checklist ➔Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant
📍 Stanford University — Palo Alto, California
Acute Myeloid Leukemia
View Study & Checklist ➔Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Core Binding Factor Alpha Subunits
View Study & Checklist ➔Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
📍 University of California, San Francisco — San Francisco, California
Psoriasis
View Study & Checklist ➔Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)
📍 Cleveland Clinic Digestive Disease & Surgery Institute (DDSI), Case Comprehensive Cancer Center — Cleveland, Ohio
Secondary Malignant Neoplasm of Retroperitoneum
View Study & Checklist ➔Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
Hematopoietic and Lymphatic System Neoplasm
View Study & Checklist ➔Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
📍 Johns Hopkins Hospital — Baltimore, Maryland
Post-ERCP Acute Pancreatitis
View Study & Checklist ➔A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Hematologic Malignancies
View Study & Checklist ➔Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
📍 Renal Associates — Montgomery, Alabama
Primary Membranous Nephropathy
View Study & Checklist ➔Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
📍 City of Hope Medical Center — Duarte, California
Acute Myeloid Leukemia With Complex Karyotype
View Study & Checklist ➔Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
📍 City of Hope Medical Center — Duarte, California
Acute Myeloid Leukemia
View Study & Checklist ➔Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
📍 Lombardi Comprehensive Cancer Center at Georgetown University Medical Center — Washington D.C., District of Columbia
Allogeneic Stem Cell Transplant Recipient
View Study & Checklist ➔Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Primary Myelofibrosis
View Study & Checklist ➔ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
📍 University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio
Acute Myelogenous Leukemia
View Study & Checklist ➔Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
📍 City of Hope Medical Center — Duarte, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Immunodeficiency
View Study & Checklist ➔Belatacept in De Novo Heart Transplantation
📍 NYU Langone Health — New York, New York
Heart Transplantation
View Study & Checklist ➔TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
📍 Stanford University — Palo Alto, California
GVHD
View Study & Checklist ➔Allo HSCT for High Risk Hemoglobinopathies
📍 Masonic Cancer Center — Minneapolis, Minnesota
Graft Failure
View Study & Checklist ➔Cord Blood Transplantation in Children and Young Adults With Blood Cancer
📍 Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York
Acute Myelogenous Leukemia
View Study & Checklist ➔Uterus Transplantation to Treat Infertility
📍 Johns Hopkins University School of Medicine — Baltimore, Maryland
Uterine Factor Infertility
View Study & Checklist ➔MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
📍 Masonic Cancer Center at University of Minnesota — Minneapolis, Minnesota
AML
View Study & Checklist ➔MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
📍 University of Minnesota Masonic Cancer Center — Minneapolis, Minnesota
Severe Aplastic Anemia
View Study & Checklist ➔Human Penile Allotransplantation
📍 Johns Hopkins University School of Medicine — Baltimore, Maryland
Amputation
View Study & Checklist ➔Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
📍 OHSU Knight Cancer Institute — Portland, Oregon
Acute Myeloid Leukemia
View Study & Checklist ➔Advancing Transplantation Outcomes in Children
📍 University of Alabama at Birmingham (Site # 71038) — Birmingham, Alabama
Kidney Transplant
View Study & Checklist ➔A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
📍 Apogee Clinical Research, LLC — Huntsville, Alabama
Primary Membranous Nephropathy
View Study & Checklist ➔Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
Hematologic Malignancies
View Study & Checklist ➔Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
📍 City of Hope Medical Center — Duarte, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
📍 Retinal Consultants of Arizona LTD, Retinal Research Institute — Phoenix, Arizona
Age-Related Macular Degeneration
View Study & Checklist ➔A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
📍 Memorial Sloan Kettering at Basking Ridge (Consent only) — Basking Ridge, New Jersey
Sickle Cell Disease
View Study & Checklist ➔Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
📍 The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
Refractory and/or Relapsed Metastatic Solid Tumors
View Study & Checklist ➔Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
📍 Children's Hospital of Los Angeles — Los Angeles, California
Acute Biphenotypic Leukemia
View Study & Checklist ➔Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
GATA2
View Study & Checklist ➔Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
📍 Northside Hospital — Atlanta, Georgia
Hematologic Disease and Disorders
View Study & Checklist ➔Belatacept in Heart Transplantation
📍 Cedars Sinai Heart Institute/ Cedars Sinai Medical (Site # 71146) — Los Angeles, California
Heart Transplant
View Study & Checklist ➔A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
📍 Stanford Cancer Center — Palo Alto, California
Graft-versus-host Disease (GVHD)
View Study & Checklist ➔225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
📍 City of Hope Medical Center — Duarte, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Early Use of Long-acting Tacrolimus in Lung Transplant Recipients
📍 Vanderbilt University Medical Center — Nashville, Tennessee
Lung Transplant; Complications
View Study & Checklist ➔A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
📍 Local Institution - 0042 — Birmingham, Alabama
Renal Allograft Recipients
View Study & Checklist ➔Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Lymphoproliferative Disorders
View Study & Checklist ➔A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
📍 Brigham & Women's Hospital- Site Number : 8400049 — Boston, Massachusetts
Kidney Transplant Rejection
View Study & Checklist ➔Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Myelodysplastic/Myeloproliferative Neoplasm
View Study & Checklist ➔Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
📍 City of Hope Medical Center — Duarte, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Leukemia
View Study & Checklist ➔Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis
📍 Horizon Eye & Lasik Center — Phoenix, Arizona
Non-infectious Anterior Uveitis
View Study & Checklist ➔Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation
📍 UCSF Benioff Children's Hospital — San Francisco, California
Liver Transplant
View Study & Checklist ➔Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant
📍 M D Anderson Cancer Center — Houston, Texas
Hematopoietic and Lymphoid System Neoplasm
View Study & Checklist ➔Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
📍 Mayo Clinic Hospital Arizona (Site #: 71144) — Phoenix, Arizona
Liver Transplant
View Study & Checklist ➔Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
📍 Johns Hopkins University — Baltimore, Maryland
Primary Immune Deficiency Disorder
View Study & Checklist ➔Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
📍 Deepa Valvi — Lexington, Kentucky
End Stage Renal Disease
View Study & Checklist ➔Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
📍 Vancouver General Hospital — Vancouver, British Columbia
Liver Transplantation
View Study & Checklist ➔Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
📍 NYU Langone Health — New York, New York
Rheumatic Disease
View Study & Checklist ➔Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
📍 Moffitt Cancer Center — Tampa, Florida
Acute Leukemia
View Study & Checklist ➔High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
📍 MD Anderson Cancer Center — Houston, Texas
Splenomegaly
View Study & Checklist ➔Trial of Cell Based Therapy for DMD
📍 Masonic Cancer Center — Minneapolis, Minnesota
Duchenne Muscular Dystrophy
View Study & Checklist ➔211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Acute Lymphoblastic Leukemia in Remission
View Study & Checklist ➔